Ignite Creation Date:
2025-12-24 @ 6:59 PM
Ignite Modification Date:
2025-12-25 @ 4:32 PM
Study NCT ID:
NCT04877457
Status:
TERMINATED
Last Update Posted:
2024-10-09
First Post:
2021-04-30
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Ocrelizumab for Preventing Clinical Multiple Sclerosis in Individuals With Radiologically Isolated Disease.
Sponsor:
Yale University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-02-15
Start Date Type:
ACTUAL
Primary Completion Date:
2023-06-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-06-12
Completion Date Type:
ACTUAL
First Submit Date:
2021-04-30
First Submit QC Date:
None
Study First Post Date:
2021-05-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-06-10
Results First Submit QC Date:
None
Results First Post Date:
2024-10-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-01
Last Update Post Date:
2024-10-09
Last Update Post Date Type:
ACTUAL